Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases

Studies investigating the effect of rituximab in children with nephrotic syndrome (NS) due to focal segmental glomerulosclerosis (FSGS) have reported conflicting results, with some concluding that patients may require additional immunosuppressive therapy to achieve and/or maintain long-term remissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambarsari, Cahyani Gita, Saraswati, Meilania, Laudza, Genta Syaifrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743143/
https://www.ncbi.nlm.nih.gov/pubmed/36518356
http://dx.doi.org/10.1159/000525776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743143/
https://www.ncbi.nlm.nih.gov/pubmed/36518356
http://dx.doi.org/10.1159/000525776

Ejemplares similares